Colin Kovacs

Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodies

The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy

Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV

The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells

Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV

Immunogenicity of COVID-19 Vaccines and Their Effect on the HIV Reservoir in Older People with HIV

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

BCL-2 antagonism sensitizes cytotoxic T cell–resistant HIV reservoirs to elimination ex vivo

Establishment of a Novel Humanized Mouse Model To Investigate <i>In Vivo</i> Activation and Depletion of Patient-Derived HIV Latent Reservoirs

Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells

Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes

Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes

HERV-K–specific T cells eliminate diverse HIV-1/2 and SIV primary isolates